Cytotoxicity Tests, Immunologic
"Cytotoxicity Tests, Immunologic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement.
| Descriptor ID |
D003601
|
| MeSH Number(s) |
E01.370.225.812.160 E05.200.812.160 E05.478.594.160 E05.940.245
|
| Concept/Terms |
Cytotoxicity Tests, Immunologic- Cytotoxicity Tests, Immunologic
- Cytotoxicity Tests, Immunological
- Cytotoxicity Test, Immunological
- Immunological Cytotoxicity Test
- Immunological Cytotoxicity Tests
- Immunologic Cytotoxicity Tests
- Cytotoxicity Test, Immunologic
- Immunologic Cytotoxicity Test
Lymphocytotoxicity Tests, Antiglobulin-Augmented- Lymphocytotoxicity Tests, Antiglobulin-Augmented
- Lymphocytotoxicity Tests, Antiglobulin Augmented
- Antiglobulin-Augmented Lymphocytotoxicity Tests
- Antiglobulin Augmented Lymphocytotoxicity Tests
- Lymphocytotoxicity Test, Antiglobulin-Augmented
- Lymphocytotoxicity Test, Antiglobulin Augmented
- Antiglobulin-Augmented Lymphocytotoxicity Test
- Antiglobulin Augmented Lymphocytotoxicity Test
Anti-Human Globulin Complement-Dependent Cytotoxicity Tests- Anti-Human Globulin Complement-Dependent Cytotoxicity Tests
- Anti Human Globulin Complement Dependent Cytotoxicity Tests
- Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent
- Cytotoxicity Tests, Anti Human Globulin Complement Dependent
- AHG-CDC Tests
- AHG CDC Tests
- AHG-CDC Test
- Anti-Human Globulin Complement-Dependent Cytotoxicity Test
- Anti Human Globulin Complement Dependent Cytotoxicity Test
|
Below are MeSH descriptors whose meaning is more general than "Cytotoxicity Tests, Immunologic".
Below are MeSH descriptors whose meaning is more specific than "Cytotoxicity Tests, Immunologic".
This graph shows the total number of publications written about "Cytotoxicity Tests, Immunologic" by people in this website by year, and whether "Cytotoxicity Tests, Immunologic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2001 | 0 | 3 | 3 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 0 | 1 | 1 |
| 2008 | 1 | 2 | 3 |
| 2010 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cytotoxicity Tests, Immunologic" by people in Profiles.
-
Smith HL, Saia G, Lobikin M, Tiwari T, Cheng SC, Molrine DC. Characterization of serum anti-diphtheria antibody activity following administration of equine anti-toxin for suspected diphtheria. Hum Vaccin Immunother. 2017 11 02; 13(11):2738-2741.
-
Wallace A, West K, Rothman AL, Ennis FA, Lu S, Wang S. Post-translational intracellular trafficking determines the type of immune response elicited by DNA vaccines expressing Gag antigen of Human Immunodeficiency Virus Type 1 (HIV-1). Hum Vaccin Immunother. 2013 Oct; 9(10):2095-102.
-
Hamada H, Bassity E, Flies A, Strutt TM, Garcia-Hernandez Mde L, McKinstry KK, Zou T, Swain SL, Dutton RW. Multiple redundant effector mechanisms of CD8+ T cells protect against influenza infection. J Immunol. 2013 Jan 01; 190(1):296-306.
-
Beaumier CM, Jaiswal S, West KY, Friberg H, Mathew A, Rothman AL. Differential in vivo clearance and response to secondary heterologous infections by H2(b)-restricted dengue virus-specific CD8+ T cells. Viral Immunol. 2010 Oct; 23(5):477-85.
-
Wright SE, Quinlin IS, Rewers-Felkins KA, Dombrowski KE, Phillips CA. Retention of immunogenicity produced by mucin 1 peptides with glycosylation site substitutions. Immunopharmacol Immunotoxicol. 2010 Dec; 32(4):647-55.
-
Garcia-Hernandez Mde L, Hamada H, Reome JB, Misra SK, Tighe MP, Dutton RW. Adoptive transfer of tumor-specific Tc17 effector T cells controls the growth of B16 melanoma in mice. J Immunol. 2010 Apr 15; 184(8):4215-27.
-
Woodworth JS, Wu Y, Behar SM. Mycobacterium tuberculosis-specific CD8+ T cells require perforin to kill target cells and provide protection in vivo. J Immunol. 2008 Dec 15; 181(12):8595-603.
-
Resende DM, Caetano BC, Dutra MS, Penido ML, Abrantes CF, Verly RM, Resende JM, Pil?-Veloso D, Rezende SA, Bruna-Romero O, Fernandes AP, Gazzinelli RT. Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells. Vaccine. 2008 Aug 18; 26(35):4585-93.
-
Dar A, Nichani AK, Benjamin P, Lai K, Soita H, Krieg AM, Potter A, Babiuk LA, Mutwiri GK. Attenuated cytokine responses in porcine lymph node cells stimulated with CpG DNA are associated with low frequency of IFNalpha-producing cells and TLR9 mRNA expression. Vet Immunol Immunopathol. 2008 Jun 15; 123(3-4):324-36.
-
Zhou J, Chen J, Zhong R, Mokotoff M, Shultz LD, Ball ED. Targeting gastrin-releasing peptide receptors on small cell lung cancer cells with a bispecific molecule that activates polyclonal T lymphocytes. Clin Cancer Res. 2006 Apr 01; 12(7 Pt 1):2224-31.